PETX

Aratana Therapeutics, Inc. Press Releases

$6.15
*  
0.14
2.33%
Get PETX Alerts
*Delayed - data as of May 2, 2016  -  Find a broker to begin trading PETX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing

Aratana Therapeutics to Present at Bank of America Merrill Lynch Healthcare Conference
5/2/2016 9:00:00 AM - PR Newswire
▲0.82 % Price Change since this news event. The Volume Ratio is 0.63.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Aratana Therapeutics to Discuss Global Strategic Collaboration with Elanco Animal Health
4/25/2016 4:10:00 PM - PR Newswire
▼-11.00 % Price Change since this news event. The Volume Ratio is 9.33.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Aratana, Elanco Announce Global Strategic Collaboration
4/25/2016 4:05:00 PM - PR Newswire
▼-11.00 % Price Change since this news event. The Volume Ratio is 9.33.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Why Patents are the Lifeblood of Biotech Companies
4/25/2016 9:36:00 AM - AccessWire




Aratana Therapeutics to Report First Quarter 2016 Financial Results
4/14/2016 4:05:00 PM - PR Newswire
▼-4.21 % Price Change since this news event. The Volume Ratio is 0.61.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Biotech Volatility Both Good And Bad
4/7/2016 9:30:00 AM - AccessWire


Aratana Therapeutics to Present GALLIPRANT® (grapiprant tablets) Pivotal Data
3/31/2016 9:00:00 AM - PR Newswire
▲18.73 % Price Change since this news event. The Volume Ratio is 1.98.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Aratana Therapeutics Files for Second FDA Approval
3/22/2016 4:05:00 PM - PR Newswire
▲26.54 % Price Change since this news event. The Volume Ratio is 1.08.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Aratana Therapeutics Granted First FDA Approval
3/21/2016 2:56:00 PM - PR Newswire


Aratana Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results
3/14/2016 4:05:00 PM - PR Newswire
▲33.41 % Price Change since this news event. The Volume Ratio is 1.54.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Aratana Therapeutics to Present at Barclays Healthcare Conference
3/2/2016 5:00:00 PM - PR Newswire
▲70.83 % Price Change since this news event. The Volume Ratio is 2.82.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Aratana Therapeutics to Report Fourth Quarter and Full Year 2015 Financial Results
2/23/2016 4:15:00 PM - PR Newswire
▲73.73 % Price Change since this news event. The Volume Ratio is 0.84.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Aratana Therapeutics Receives Technical Section Complete Letter for Effectiveness for AT-002
2/23/2016 8:40:00 AM - PR Newswire
▲83.04 % Price Change since this news event. The Volume Ratio is 1.18.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Aratana Therapeutics Receives Technical Section Complete Letter for Effectiveness for AT-003
2/22/2016 8:40:00 AM - PR Newswire
▲96.49 % Price Change since this news event. The Volume Ratio is 0.87.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Aratana Therapeutics Files for First European Approval
2/17/2016 4:05:00 PM - PR Newswire
▲83.04 % Price Change since this news event. The Volume Ratio is 1.55.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day